| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 3294134 | Gastroenterology | 2012 | 15 Pages | 
Abstract
												Aspirin is an inhibitor of mTOR and an activator of AMPK, targeting regulators of intracellular energy homeostasis and metabolism. These could contribute to its protective effects against development of CRC.
											Keywords
												ADPS6 kinase 1human antigen RS6 ribosomal proteinNDRG14E-BP1eIF4ES6K1LC3AMPKmTORNSAIDMEFmRNAACCPI3KPBSeukaryotic translation initiation factor 4Emessenger RNASmall interfering RNAsiRNAAdenosine TriphosphateATPadenosine diphosphateadenosine monophosphate–activated protein kinaseacetyl-CoA carboxylaseOncogenenonsteroidal anti-inflammatory druglight chain 3Colorectal cancerColon cancerTumor suppressorphosphoinositide-3-kinasePhosphate-buffered salinemouse embryonic fibroblastMechanistic target of rapamycinChemopreventionHuRCRC
												Related Topics
												
													Health Sciences
													Medicine and Dentistry
													Gastroenterology
												
											Authors
												Farhat V.N. Din, Asta Valanciute, Vanessa P. Houde, Daria Zibrova, Kevin A. Green, Kei Sakamoto, Dario R. Alessi, Malcolm G. Dunlop, 
											